Beverly Green, MD, MPH, is a physician scientist known for pioneering work in preventive and evidence-based medicine. With a goal of improving systems of care, she designs and evaluates programs that make effective treatment easier for patients to follow through with — and easier for providers to deliver.
Dr. Green’s research has a strong public health emphasis, targeting conditions that impact large proportions of the population — such as cardiovascular disease, cancer, and obesity — with an emphasis on leveraging technologies and systems-based care.
In 2022, Dr. Green published the results of the BP-CHECK study, which compared the accuracy and acceptability of ways to diagnose high blood pressure. With a $2.8 million award from PCORI (the Patient-Centered Outcomes Research Institute), the study compared blood pressures taken in clinic, at home, and at validated blood pressure kiosks to the 24-hour blood pressure test that is currently considered the gold standard for diagnosing hypertension. Blood pressures taken at home were the most accurate and most preferred method for diagnosing hypertension. She is working with Kaiser Permanente Washington on their efforts to integrate home blood pressure monitoring into clinical care.
Dr. Green also co-led a National Cancer Institute study that evaluated the effectiveness of home-based human papilloma virus (HPV) kits to increase completion of cervical cancer screening. Compared to reminders and educational materials, mailed self-sample HPV kits increased cervical cancer screening rates by almost 15%. The results were published in JAMA, Strategies to Increase Cervical Cancer Screening With Mailed Human Papillomavirus Self-Sampling Kits. She is an investigator on a new National Cancer Institute study that is evaluating whether in clinic distribution of HPV self-testing kits or this plus mailed HPV kits increase cervical cancer screening rates compared to usual care. The study is being conducted in 42 safety net clinics in Oregon and Washington State.
Dr. Green’s previous research has shown that:
She is a member of the Target BP steering committee, an initiative to increase hypertension control that is sponsored by the American Health Association. She previously served on the steering committee of the National Colorectal Cancer Round Table (an elected position) and the U.S. Validated Blood Pressure Device Review Committee.
Dr. Green was honored by Kaiser Permanente Washington in 1999 for her contributions to clinical quality improvement and was a finalist for the organization's 2004 Lifetime Achievement Award. She was an associate editor for the American Journal of Preventive Medicine from 2009 to 2014, and continues to serve on its editorial board. She is a fellow of the American Heart Association, an honor given for contributions to the field.
Dr. Green is a clinical professor at the University of Washington School of Medicine, Department of Family Medicine, and a professor at the Kaiser Permanente Bernard J. Tyson School of Medicine, Department of Health Systems Science.
Margolis KL, Crain AL, Green BB, O'Connor PJ, Solberg LI, Beran M, Bergdall AR, Pawloski PA, Ziegenfuss JY, JaKa MM, Appana D, Sharma R, Kodet AJ, Trower NK, Rehrauer DJ, McKinney Z, Norton CK, Haugen P, Anderson JP, Crabtree BF, Norman SK, Sperl-Hillen JM. Comparison of explanatory and pragmatic design choices in a cluster-randomized hypertension trial: effects on enrollment, participant characteristics, and adherence. Trials. 2022 Aug 17;23(1):673. doi: 10.1186/s13063-022-06611-3. PubMed
Green BB, Larson AE, Huguet N, Angier H, Valenzuela S, Marino, M. High blood pressure reduction, health insurance status, and social deprivation index in US community health centers. AJPM Focus. 2022 Dec; 1(2): 100018. Published online 2022 Aug 4. doi: 10.1016/j.focus.2022.100018. PubMed
Kottke TE, Anderson JP, Zillhardt JD, Sperl-Hillen JM, O'Connor PJ, Green BB, Williams RA, Averbeck BM, Stiffman MN, Beran M, Rakotz M, Margolis KL. Association of an automated blood pressure measurement quality improvement program with terminal digit preference and recorded mean blood pressure in 11 clinics. JAMA Netw Open. 2022;5(8):e2229098. doi: 10.1001/jamanetworkopen.2022.29098. PubMed
Nicholson BD, Thompson MJ, Hobbs FDR, Nguyen M, McLellan J, Green B, Chubak J, Oke JL. Measured weight loss as a precursor to cancer diagnosis: retrospective cohort analysis of 43Â 302 primary care patients. J Cachexia Sarcopenia Muscle. 2022 Oct; 13(5): 2492-2503. Published online 2022 Jul 28. doi: 10.1002/jcsm.1305. PubMed
Pocobelli G, Ichikawa L, Yu O, Green BB, Meyers K, Gray R, Shea M, Chubak J. Validation of international classification of diseases, tenth revision, clinical modification diagnosis codes for heart failure subtypes. Pharmacoepidemiol Drug Saf. 2022 Jun 7. doi: 10.1002/pds.5489. Online ahead of print. PubMed
The findings can help guide colorectal cancer screening decisions later in life.
New study builds on findings that home tests improve screening rates.
Bev Green, doctor and scientist, has tips for monitoring your blood pressure without leaving your house.
AARP, June 3, 2024
Research finds that mailing HPV test kits directly to patients increases cervical cancer screening rates.